跳转至

◀返回

情感抑制

情感抑制（也称为情感平淡、冷漠或情感迟钝）在医学上被认为是当前情绪状态的强度降低或平缓到了正常水平以下哦。[1][2][3] 这会减弱或压抑一个人在摄入药物之前已经感受到的真实情绪呢。举个例子，一个目前感到有点焦虑或情绪不稳定的人，可能会开始感到非常冷漠、中立、不在乎，情感上一片空白。这也影响了一个人通过肢体语言、语调和面部表情表达情绪状态的程度嘛。

值得注意的一点是，虽然情绪强度的降低有时是有益的（例如，在情绪不稳的患者中减弱愤怒反应），但在其他时候可能是有害的哦（例如，在近亲的葬礼上表现出情感冷漠）。[4]

情感抑制通常伴随着其他同时发生的效应，如动力抑制（motivation suppression）、思维减速（thought deceleration）和分析能力抑制（analysis suppression）。它最常见于中等（Common）剂量的抗精神病药化合物的影响下，如喹硫平、氟哌啶醇（haloperidol）和利培酮（risperidone）。[1][5] 然而，在严重（Heavy）剂量的解离剂、[6][7] SSRI [4][8] 和GABA能抑制剂[9] 的影响下，它也可能以不太一致的形式出现呢。

目录

体验报告

在我们的体验索引中，描述此效应的轶事报告包括：

  • Experience:1.2 g gabapentin, alcohol, and half of 150 mg Effexor XR - Pretty lovely for socializing and giggles
  • Experience:100-350mg - Phenylpiracetam in daily life
  • Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea_-_Asymmetrical_Terror_and_the_Geometric_Sea.md)
  • Experience:3-MMC: Weak substitute? No way!
  • Experience:3mg Etizolam - A Comedown Drug
  • Experience:Nutmeg (8 teaspoons) - My Mom Introduces Me To Genesis and Other Things_-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things.md)
  • Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death_-_Overdosing_and_Terifying_Ego_Death.md)

另见

外部链接

参考文献

  1. ↑ 1.0 1.1 Ueda, Satoshi; Sakayori, Takeshi; Omori, Ataru; Fukuta, Hajime; Kobayashi, Takashi; Ishizaka, Kousuke; Saijo, Tomoyuki; Okubo, Yoshiro (2016). "Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis". Neuropsychiatric Disease and Treatment: 265. doi:10.2147/NDT.S99577. ISSN 1178-2021. 
  2. ↑ "Neurocognitive Disorders". Diagnostic and statistical manual of mental disorders (5th ed.): 609. 2013. doi:10.1176/appi.books.9780890425596.dsm17. 
  3. ↑ Gur, R. E; Kohler, C. G; Ragland, J D.; Siegel, S. J; Lesko, K.; Bilker, W. B; Gur, R. C (2006). "Flat Affect in Schizophrenia: Relation to Emotion Processing and Neurocognitive Measures". Schizophrenia Bulletin. 32 (2): 279–287. doi:10.1093/schbul/sbj041. ISSN 0586-7614. 
  4. ↑ 4.0 4.1 Sansone, R. A., Sansone, L. A. (October 2010). "SSRI-Induced Indifference". Psychiatry (Edgmont (Pa.: Township)). 7 (10): 14–18. ISSN 1555-5194. 
  5. ↑ Moncrieff, J.; Cohen, D.; Mason, J. P. (2009). "The subjective experience of taking antipsychotic medication: a content analysis of Internet data". Acta Psychiatrica Scandinavica. 120 (2): 102–111. doi:10.1111/j.1600-0447.2009.01356.x. ISSN 0001-690X. 
  6. ↑ Vollenweider, F. X. (31 December 2001). "Brain mechanisms of hallucinogens and entactogens". Dialogues in Clinical Neuroscience. 3 (4): 265–279. doi:10.31887/DCNS.2001.3.4/fxvollenweider. ISSN 1958-5969. 
  7. ↑ Micallef, J; Tardieu, S; Gentile, S; Fakra, E; Jouve, E; Sambuc, R; Blin, O (2003). "Évaluation psychocomportementale de l'administration de faible dose de kétamine chez le sujet sain". Neurophysiologie Clinique/Clinical Neurophysiology. 33 (3): 138–147. doi:10.1016/S0987-7053(03)00028-5. ISSN 0987-7053. 
  8. ↑ Bolling, Madelon Y.; Kohlenberg, Robert J. (2004). "Reasons for Quitting Serotonin Reuptake Inhibitor Therapy: Paradoxical Psychological Side Effects and Patient Satisfaction". Psychotherapy and Psychosomatics. 73 (6): 380–385. doi:10.1159/000080392. ISSN 0033-3190. 
  9. ↑ Oscar-Berman, M., Bowirrat, A. (September 2005). "Genetic influences in emotional dysfunction and alcoholism-related brain damage". Neuropsychiatric Disease and Treatment. 1 (3): 211–229. ISSN 1176-6328.